Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 22.8K sh | Mar 20, 2026 |
| 9 | You Harry L.Director, 10% Owner | Grant or award | A | — 2.88M sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Hyman JonathanChief Technology Officer | Grant or award | A | — 89.6K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 100.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 176.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 211.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Brown HaydenDirector, President & CEO | Option exercise | M | — 17.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Bendza Gary MarkEVP, CFO | Grant or award | A | — 109.7K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 18.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 32.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Grant or award | A | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 18.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 638.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 9,167 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 162.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Shlimak AnnaSee Remarks | Tax withholding | F | $25K 9,767 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Smith Robert Paul JRChief Commercial Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aulestia Bernadette S.Director | Grant or award | A | — 905 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 375.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Grant or award | A | — 181.3K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Gessert EricaChief Financial Officer | Option exercise | M | — 9,699 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 487.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 572.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | AmundiDirector, 10% Owner | Disposition to issuer | D | — 100.0K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Tax withholding | F | $1,849 1,249 sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 375.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Disposition to issuer | D | — 562.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Aranda RichardChief Medical Officer | Grant or award | A | — 157.5K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Nixon D. GailSenior VP, Human Resources | Option exercise | M | — 123.5K sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Stewart John REVP - Chief Financial Officer | Tax withholding | F | $10K 643 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 440.0K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Grant or award | A | — 22.8K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Gessert EricaChief Financial Officer | Option exercise | M | — 8,433 sh | Mar 20, 2026 traded Mar 18, 2026 |
| 9 | Peterson CarynEVP, Regulatory Affairs | Disposition to issuer | D | — 126.7K sh | Mar 20, 2026 traded Mar 19, 2026 |
| 9 | Giraudo BryanCOO/CFO | Disposition to issuer | D | — 693.8K sh | Mar 20, 2026 traded Mar 19, 2026 |